Return to HealthandAge.com NIH Age Pages
HomeIndex





Hearts & Arteries

National Institutes of Health
Hearts & Arteries, NIH Publication Number 94-3738

 

PreviousTable Of ContentsNext


Hearts & Arteries

 

"Bells and whistles" scientists call them, the intricate devices by which cells get their work done, and it's not hard to see why. Consider the cellular events that lead up to a heart beat: First there's the electrical impulse along the cell's membrane; then channels open in the cell membrane allowing sodium to flow into the cell; then more channels open and calcium enters and binds to a tiny structure near the membrane; then much more calcium explodes out of that structure into the cell's inner fluid and combines with another protein; then that protein changes shape to allow two other proteins to come together; then the joined proteins move in such a way as to shorten the cell, pulling the ends of the cell inward-this is the actual contraction-and then the whole process reverses itself as the heart relaxes. This is what happens in a heart muscle cell (myocyte) every time the heart beats.

Over the last two decades, scientists have delved into this wealth of bells and whistles and come up with some intriguing finds. They have discovered age-related changes in myocytes that help explain changes in the heart as a whole; begun to see how these changes could interact with disease processes; and found clues to how exercise affects the biochemistry of cells. The result is a string of new insights and novel hypotheses about aging and disease.


Contraction and Relaxation Prolonged

Take for example, the bells and whistles that regulate how long it takes a myocyte to contract and relax. Since the 1950s, scientists have known that calcium plays a major role in the contraction and relaxation of muscle, including heart muscle. Calcium entering the myocyte's inner fluid or cytosol binds with other contractile proteins to bring about contraction; calcium leaving the cytosol allows the cell to relax.

When scientists learned, in the early 1970s, that muscle from older hearts takes longer to relax than muscle from younger hearts, they speculated that it could have something to do with calcium. A way to test this hypothesis came to hand about a decade later via a protein called aequorin. Aequorin binds to calcium and gives off a blue light, showing how much calcium is in a cell at any one time. When Edward Lakatta and Clive Orchard at NIA injected aequorin into myocytes within heart muscle in laboratory dishes, the blue light showed that the calcium levels, after a contraction, fell more slowly in older myocytes. Or putting it in biologists' terms, the calcium transient was longer. Here was the cellular mechanism that explained why hearts relax more slowly with age.

Here also is a good example of how discoveries in the realm of cellular biology have begun to throw light on the relationships between aging and disease. The longer calcium transient, for one thing, appears to be a way that the heart adjusts to age, or more specifically to the stiffer arteries that accompany aging. "It makes sense from an engineering standpoint to have a longer contraction if you're pumping blood into stiffer vessels," points out Lakatta. "The down-side," he adds, "is that when you alter the kinetics of calcium cycling in the cell, various stresses can more easily throw the calcium out of balance."

And when calcium cycling gets out of balance, levels of calcium may oscillate and chaos can ensue. Individual cells may fire off rapidly and independently, resulting in arrhythmias-variations from the normal heart beat rhythm-and fibrillation, which is a very rapid twitching of individual muscle fibers. Fibrillation in the left ventricle leads quickly to acute heart failure and to death if not treated.

Heart failure rises exponentially with advancing age, and studies of calcium oscillations in the myocytes suggest possible reasons. Older hearts are more prone to spontaneous calcium oscillations than younger hearts and it takes fewer oscillations in the older heart to bring about fibrillation. As a result, some scientists speculate that age-related changes in calcium cycling-changes that initially help the heart adapt to stiffer arteries and larger loads-eventually make it more vulnerable to calcium-dependent arrhythmias and heart failure.



The Calcium Pump

The next question, of course, was why: Why is the calcium transient longer in older cells? Perhaps, bio-chemists speculated, it is because the calcium stays in the inner fluid longer.

Each myocyte has a structure, or organelle, that stores calcium. Called the sarcoplasmic reticulum, it releases calcium into the inner fluid before contraction and removes calcium from the inner fluid after contraction. Could the calcium be spending longer in the inner fluid because the sarcoplasmic reticulum was not removing it as quickly in older cells?

With technology that became available in the late 1970s, researchers were able to answer this question. Jeffrey Froehlich and his colleagues at NIA isolated the sarcoplasmic reticulum from the rest of the cell, placed it in a test tube, and then added calcium. The result confirmed their hypothesis: The sarcoplasmic reticulum took up the calcium more slowly in the samples from older animals than in those from younger animals.

Subsequent studies confirmed that the sarcoplasmic reticulum-or more exactly, a protein on this organelle-removes calcium from the inner fluid more slowly in older hearts. Researchers have found that older cells have lower amounts of this particular protein, often called the calcium pump protein because it removes the calcium in a series of repeated movements. So the sarcoplasmic reticulum removes calcium from the inner fluid more slowly in older hearts because there are fewer calcium pump proteins to do the work.

Once scientists had learned about the pump protein, the next question was about that protein's gene. Proteins make up a huge category that includes enzymes, growth factors, hormones-almost all the substances that are responsible for the day-to-day functioning of living organisms. Proteins are produced by genes in the nucleus of every cell. Each protein has its own gene. Cells translate gene codes into proteins through a complex, multistep process called gene expression. Any alteration in this process can lead to changes in the end product, the protein.

In the case of the pump protein, the gene that produces it is only about half as active in older hearts as in younger hearts, according to recent studies. On the more hopeful side, exercise conditioning may alter the picture. (see Exercise and the Aging Myocyte, below).

Researchers are beginning to find out why exercise is so good for the heart by looking at how if affects heart muscle cells or myocytes. At NIA, scientists have found that laboratory animals that exercise regularly have hearts that work more like the hearts of younger animals.

Now NIA grantee Charlotte Tate is exploring the molecules and genes in myocytes to find out why exercise makes a difference.

In an early experiment, Tate and her colleagues at the Baylor College of Medicine compared three groups of rats. One older group was put on an endurance training program, running on a treadmill five days a week. One older group remained sedentary, and the third, a middle-age group, was also sedentary.

One of the key differences among the groups turned out to be how quickly calcium was removed from the cell's inner fluid after a contraction. In the older exercising group, calcium made its exit faster than in the sedentary older group. The rate of removal in the older exercising group was close to that in the middle-age group. The scientists concluded that at least one reason exercise improves heart performance is that it somehow allows cells to remove calcium from the inner fluid at a faster rate.

The next step is to delve even deeper into this mechanism: Why does calcium exit from the inner fluid faster after endurance training? Tate's laboratory, now at the University of Houston, is looking for clues in the pump protein that transports calcium out of the inner fluid. Endurance training may alter the way this pump protein is manufactured and thus may help explain the impact of regular exercise.


A Longer Action Potential

In addition to the calcium transient, two other clusters of events in myocytes seem to be affected by age. One is the action potential. This is a transient alteration in the amounts of positive and negative charges on either side of the myocyte membrane. The action potential triggers the opening of sodium and then calcium channels in the membrane.

The action potential is prolonged in older hearts and may contribute to the longer calcium transient, although the connection, if it exists, is still not clear. Researchers studying changes in the action potential think an age-related switching of genes is a possibility, but the mechanisms and the effects are uncertain.


Contractile Proteins

The other mechanisms that change with age involve the contractile proteins-actin, myosin, troponin, and others-that interact to shorten, or contract, the myocyte. These contractile proteins pass through a series of steps, triggered by calcium, which bring actin and myosin together into "crossbridges." The crossbridges use energy released during the transaction to shorten the cell. With age, one part of the crossbridge alters-the part called the myosin heavy chain.

The myosin heavy chain can be produced in two slightly different forms, one dubbed alpha, the other beta. In experimental animals, the alpha myosin heavy chain decreases with age, while the beta increases. The same seems to be true in the human atrium. When the proportion of alpha myosin heavy chain is reduced in isolated cells, the contraction speed is slower.

Changes in the myosin heavy chain have been traced back to the genes involved-alpha is expressed less with age, beta more-but why the genes should switch activity remains a mystery. "It's one of the cutting edge questions," says Lakatta. "There's no doubt that some genes change their activity with aging. We just don't know why or how yet." In general, though, the expression of genes in the aging heart tends to revert back to patterns of gene expression seen in the fetus.

Scientists are beginning to understand what happens in the cells and molecules of arteries during atherosclerosis-the build-up of fatty deposits on the inside of arteries. Atherosclerosis significantly increases the risk of heart disease and stroke.

Blood vessels consist of several kinds of cells. Lining the inner surface are endothelial cells which are attached to a basement membrane. Moving toward the outer surface, a layer of tissue called the intima comes next, followed by the inner elastic membrane. Next comes a layer of vascular smooth muscle cells between layers of elastin and finally an outer layer of connective tissue.

In the normal process of aging, some vascular smooth muscle cells migrate to the intima, which grows larger. In atherosclerosis, some of these cells in the intima invade the basement membrane and form clumps of tissue that narrow the passageway inside the artery (the lumen). The process seems to be triggered, at least partly, by the build-up of fatty streaks with cholesterol along the artery walls.

This much was known by 1992 when Rebecca Pauly, Michael Crow, and others at NIA set out to learn what happened in the vascular smooth muscle cells during atherosclerosis. Studying the cells in laboratory cultures, they found that these cells are able to invade the basement membrane because they secrete enzymes that attack the protein in the membrane. They also found that specific antibodies and other substances could keep the enzymes from attacking the membrane.

The next step is to find out what makes the smooth muscle cells secrete the damaging enzymes and invade the basement membrane. Once the scientists have identified the steps that lead to this event, it may be possible to design strategies to prevent atherosclerosis.


Enlargement

Myocytes undergo another interesting alteration with age: They get larger. Individual myocytes do not divide like other cells in the body. However, they do increase in size by 20 to 40 percent during adult life. Others die and are replaced by collagen. This enlargement of the remaining myocytes seems to be the principal mechanism for the thickening of the heart walls - the hypertrophy - that occurs during normal aging.

Much evidence suggests that myocyte enlargement and the consequent thickening of the heart walls are ways that the heart adjusts to increased loads, especially from the growing stiffness of the arteries. Extra loads may also be imposed by disease.

One reason cardiovascular researchers are so intrigued by myocyte enlargement is because of its possible links to disease. While enlargement seems to occur in response to aging and stiffening arteries, it is exaggerated by disease, such as coronary artery disease and high blood pressure. Enlargement occurs with high blood pressure regardless of age.

While myocyte enlargement seems to be one way the heart adapts to increased loads, there is also evidence that at the oldest ages, it no longer adapts as much. Older animals have less enlargement in response to heart overloads than younger animals. This failure or slowing of the adaptive response may explain why 80-year-olds are much more likely to experience heart failure following a heart attack than 60-year-olds.

In fact, according to one school of thought, heart failure rises with age for the same reason. That is, the reason older people have a higher risk of heart failure is not just because their hearts have had longer to deteriorate. It is because of specific, age-associated changes in healthy hearts and blood vessels that hinder the heart's ability to adapt to disease states. In this view, normal age-associated changes are risk factors for heart disease in older persons.

Selected Readings

Froehlich JP, Lakatta EG, Beard
E, Spurgeon HA, Weisfeldt ML, and Gerstenblith G. Studies of sarcoplasmic reticulum function and contraction duration in young adult and aged rat myocardium. Journal of Molecular and Cellular Cardiology 10:427-438, 1978.

Lakatta EG, Gerstenblith G, Angell CS, Shock NW, and Weisfeldt MI. Prolonged contraction duration in aged myocardium. Journal of Clinical Investigation 55:61-68, 1975.

O'Neill L, Holbrook NJ, Fargnoli J, and Lakatta EG. Progressive changes from young adult age to senescence in mRNA for rat cardiac myosin heavy chain genes. Cardioscience 2:1-5, 1991.

Orchard CH and Lakatta EG. Intracellular calcium transients and developed tensions in rat heart muscle. A mechanism for the negative interval-strength relationship. Journal of General Physiology 86:637-651, 1985.

Pauly RR, Passaniti A, Crow M, Kinsella JL, Papadopoulos N, Monticone R, Lakatta EG, and Martin GR. Experimental models which mimic the differentiation and dedifferentiation of vascular cells. Circulation 86 (Supplement III): III68-73, 1992.

Spurgeon HA, Steinbach MF, and Lakatta EG. Chronic exercise prevents characteristic age-related changes in rat cardiac contraction. American Journal of Physiology 244 (Heart Circulation Physiology 132): H513-518, 1983.

Tate CA, Taffet GE, Hudson ED, Blaylock SL, McBride RP, and Michael LH. Enhanced calcium uptake of cardiac sarcoplasmic reticulum in exercise-trained old rats. American Journal of Physiology 258 (Heart Circulation Physiology 27): H431-435, 1990.

Wei JY, Spurgeon HA, and Lakatta EG. Excitation-contraction in rat myocardium: alterations with adult aging. American Journal of Physiology 246 (Heart Circulation Physiology 15): H784-791, 1989.

 

*****

Previous
Table Of ContentsNext

 







Reac to this page If you would like to react to this page or put your question to our moderator, click here!




Copyright © . All rights reserved.
[ Privacy Policy | Terms of use | About Us ]